K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species

K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species

Background/Objectives: With mucocutaneous candidiasis being highly prevalent in HIV patients, the emergence of fluconazole-resistant Candida species forms a major challenge in treating and eradicating these infections. The objective of this study was to establish the antifungal activity of K21, a me...

Full description

Bibliographic Details
Main Authors: Cathy N. John, Pedro M. D. S. Abrantes, Bhupesh K. Prusty, Dharam V. Ablashi, Charlene W. J. Africa
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Microbiology
Subjects:
HIV-associated candidiasis
antimicrobial compounds
Candida
fluconazole
antifungal susceptibility
broth microdilution
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01021/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.01021/full

Similar Items